REVIEW ARTICLE Mitochondrial disorders and general anaesthesia: a case series and review
|
|
- Kristian Gordon
- 6 years ago
- Views:
Transcription
1 British Journal of Anaesthesia 100 (4): (2008) doi: /bja/aen014 Advance Access publication February 19, 2008 REVIEW ARTICLE Mitochondrial disorders and general anaesthesia: a case series and review E. J. Footitt 1, M. D. Sinha 1, J. A. J. Raiman 1, A. Dhawan 3, S. Moganasundram 2 and M. P. Champion 1 * 1 Department of Paediatric Metabolic Medicine and 2 Department of Anaesthesia, Evelina Children s Hospital, Guy s and St Thomas NHS Foundation Trust, Lambeth Palace Road, London SE1 7EH, UK. 3 Department of Paediatric Hepatology, King s College Hospital, Denmark Hill, London SE5 9RS, UK *Corresponding author. michael.champion@gstt.nhs.uk Patients with mitochondrial disease are at risk of metabolic decompensation and often require general anaesthesia (GA) as part of their diagnostic work up and subsequent management. However, the evidence base for the use of GA is limited and inconclusive. We have documented the practice and outcome in the use of GA in paediatric patients with mitochondrial disease using a retrospective case review study of 38 mitochondrial patients who had undergone 58 anaesthetics within the regional metabolic service for the period A variety of anaesthetic agents were used and the pattern of use reflects that seen in standard paediatric practice. There were no episodes of malignant hyperthermia and no documented intraoperative events attributable to the GA. Three postoperative adverse events were noted; one episode of hypovolaemia, one episode of acute on chronic renal failure, and one episode of metabolic decompensation 12 h post-muscle biopsy. Despite theoretical concern about this group of patients, adverse events after GA are rare and in most cases unrelated to the anaesthesia. Further prospective studies of GA in mitochondrial disease are required to create evidence-based clinical guidelines for safe practice. Br J Anaesth 2008; 100: Keywords: anaesthesia, general; complications; metabolism, ATP; metabolism, lactate; surgery, paediatric Mitochondria are double-membrane bound, intracellular organelles present in all cells except erythrocytes. Their primary function is the generation of adenosine triphosphate (ATP) via aerobic respiration. However, mitochondria also host several other metabolic pathways, including the tricarboxylic acid (TCA) cycle, urea cycle, b-fatty acid oxidation, and lipid and cholesterol synthesis. The term mitochondrial disorder refers to the group of conditions caused by impairment of the respiratory chain which is involved in the generation of ATP by oxidative phosphorylation. 17 Mitochondrial disorders represent a biochemically and clinically diverse group of conditions that can affect any part of the body, with organs with a high energy requirement such as brain, muscle, liver, heart, and kidney being particularly vulnerable. Historically, mitochondrial disorders were considered to be only a neuromuscular disease; however, due to the ubiquitous nature of oxidative phosphorylation, a defect of the respiratory chain should be considered in a variety of clinical presentations and at any age. Alongside specific clinical syndromes, mitochondrial disease should also be suspected where there is an unexplained constellation of signs with a progressive course involving seemingly unrelated organs or tissues. 14 The genetic basis of mitochondrial disease is an advancing field of research and its complexities have a major impact upon clinical disease and management. The mitochondrion is unique among human organelles as each contains several copies of a small, circular, double-stranded mitochondrial DNA molecule (mtdna). The vast majority of mitochondrial proteins, however, including most of the proteins involved in electron transport, are encoded by nuclear genes. 46 Defects in nuclear DNA may be inherited in an autosomal recessive, dominant, or X-linked pattern. mtdna point mutations are maternally inherited and show huge phenotypic heterogeneity. 17 There are thousands of mtdna molecules per cell and millions per individual and any mtdna mutation may # The Board of Management and Trustees of the British Journal of Anaesthesia All rights reserved. For Permissions, please journals.permissions@oxfordjournals.org
2 Mitochondrial disorders and general anaesthesia affect all (homoplasmy) or only part (heteroplasmy) of the total mitochondria in each cell. The notion that the percentage of mutant mtdna load contributes to disease expression is a fundamental concept in mitochondrial disease. The phenotypic presentation of any particular mutation is therefore dependent on a number of factors: the severity of the DNA mutation, the proportion of mitochondria affected, and the susceptibility of various tissues to impaired mitochondrial energy metabolism. 417 Diagnostic confirmation is not straightforward in mitochondrial disease and a high index of clinical suspicion is essential. A multi-system search for disease is warranted to identify further organ systems affected that were not clinically apparent at presentation. Initial screening tests for the presence of a mitochondrial disorder include the determination of lactate pre- and post-prandially. 14 A persistent hyperlactaemia with elevated lactate/pyruvate ratios is highly suggestive of a respiratory chain disorder and should prompt further investigation. Not all patients with respiratory chain disorders will demonstrate these abnormalities, however, and radiological imaging may provide further supportive (although not diagnostic) information alongside the clinical picture. In particular, brain MRI may show characteristic abnormalities with lytic lesions in the basal ganglia and thalamus, sometimes extending into the midbrain. Thus, clinical features alone are rarely pathognomonic in mitochondrial disease and although laboratory and radiological investigations provide important clues, muscle biopsy remains an essential part of the diagnostic process. Muscle is almost always involved to some extent in inborn errors of mitochondrial metabolism and histochemical, electron microscopic, and biochemical studies (including estimation of respiratory chain enzyme function) on skeletal muscle allow definitive diagnosis in the majority of cases. 4 Open muscle biopsy under general anaesthesia (GA) is preferred to ensure suitability of biopsy material for respiratory chain enzyme analysis. GA is therefore a common requirement for these patients, both for diagnosis and for ongoing disease management such as gastrostomy or central line insertion. As with many disorders of intermediary metabolism, children with mitochondrial disorders are at risk of metabolic decompensation. This may occur with intercurrent illness or reduced oral intake/fasting and rapidly result in a lactic acidosis leading to metabolic encephalopathy. At present, treatment remains limited and does not alter the disease course. It is largely supportive and children with multiple, often complex neuro-developmental problems should be cared for in multi-professional teams. Management involves supplementation with co-factors, nutritional support, and medical treatment of complications such as metabolic decompensation and seizures. Advice on the avoidance of certain drugs which are known to interfere with normal mitochondrial function such as valproate and barbituarates is also essential. Although it poses a challenge to clinicians, genetic counselling also forms an important aspect of care for the family of a child with mitochondrial disease Mitochondria are a potential site of action for general anaesthetic agents 20 and it is feasible that children with mitochondrial disease will respond abnormally to anaesthetic drugs. There are various concerns with regard to GA in this patient group, with a generally held belief that patients with mitochondrial disease are at increased risk during anaesthesia. These concerns in part relate to the general stress response to surgery which may be particularly detrimental in this patient group, but also to the use of the anaesthetic agents themselves. However, the evidence base in the literature for this belief is limited (Table 1) It consists predominantly of case reports and short patient series and it is most notable for the variety of anaesthetic approaches and variable patient response. It provides little useful evidence base or guidance for clinicians and anaesthetists involved in the care of these complex patients. Our aim was to document current practice and the incidence of adverse events occurring during GA in a series of children with mitochondrial disease, to assist the development of evidence-based guidelines. Methods We undertook a retrospective case review study of mitochondrial patients who had undergone GA for surgical procedures within the regional metabolic service for the period The indication for GA was based on clinical need. Eligible patients were identified from the paediatric metabolic database. Inclusion criteria: children of any age with mitochondrial disorder diagnosed as per the modified Walker diagnostic criteria for respiratory chain disorders in children. 1 These criteria comprise major and minor features in various clinical, histology, enzymology, functional, and molecular parameters to produce a definite, probable, or possible diagnosis of respiratory chain disorder (Table 2). Exclusion criteria: patients who appeared on paediatric metabolic database who did not meet modified Walker criteria. We undertook a review of anaesthetic records: drug and fluid prescription charts were available from patient records. For each anaesthetic episode, we documented agents (anaesthetic), duration, and recorded stability of physiological parameters (heart rate, arterial pressure, and pulse oximetry). Any observation of intraoperative adverse event was documented from charts as recorded by the anaesthetist. Adverse events were classified as (i) mechanical/airway related or (ii) metabolic decompensation for the duration of the inpatient admission. A procedure performed within the immediate 24 h after the decision to 437
3 Footitt et al. Table 1 Summary of published literature in mitochondrial disease and GA. RCE, respiratory chain enzyme; MERRF, myoclonic epilepsy with ragged red fibres; MELAS, mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes Author (year) Number of cases Anaesthetic agent(s) Diagnosis Adverse event/outcome Driessen and colleagues (2007) Various Various RCE deficiencies Nil Vilela and colleagues (2005) 24 1 Propofol, fentanyl, sevoflurane, MERRF Nil midazolam Singh and colleagues (2004) 21 1 Propofol, alfentanil MELAS Nil Henike and Schaffranietz (2004) 11 1 Propofol, alfentanil, cis-atracurium Mitochondrial Respiratory complications encephalomyopathy Cooper and Fox (2003) 5 1 Propofol, desflurane, fentanyl, vecuronium Leigh s disease Aspiration pneumonia, progressive brain stem necrosis. Death day 62 postprocedure Morgan and colleagues (2002) Sevoflurane, fentanyl Various RCE deficiencies Nil Sharma and colleagues (2001) 18 1 Propofol, fentanyl, rocuronium, Complex I and IV deficiency Nil morphine Thiel and colleagues (2001) 22 1 Propofol, fentanyl MELAS Hyperlactaemia no clinical consequence Wallace and colleagues (1998) 25 1 Halothane, atracurium, morphine Complex III and IV deficiency Nil Finsterer and colleagues (1998) 9 1 Propofol, fentanyl, midazolam Mitochondrial myopathy Increased sensitivity to rocuronium, atracurium Casta and colleagues (1997) 3 1 Midazolam, thiopentone, fentanyl, isoflurane, pancuronium Thompson and Wahr (1997) 23 1 Midazolam, propofol, cis-atracurium, fentanyl, neostigmine undertake it was classified as an acute. All other procedures were classified as elective. We did not review pre- and postoperative biochemistry or blood gas analysis as they were not routinely performed in all patients. We do report these in patients where any adverse event was recorded. Results Forty-two cases with suspected mitochondrial disease that had undergone GA between 1989 and 2005 were identified. Four cases were excluded as they did not strictly fulfil the Walker diagnostic criteria. Thirty-eight patients underwent 69 episodes of GA, for which anaesthetic records were available in the notes of 58. Data presented are for the 58 episodes in 38 patients. Fifty episodes were elective and eight acute. The median age was 4 yr (range ) with 27 male and 11 female patients. There were 50 elective procedures. These included 27 muscle biopsies with or without lumbar puncture, eight MRI of the brain, five otolaryngological procedures, five central line insertions, four gastrostomy insertions, and one liver transplant. There were eight acute procedures Complex I, III, and IV deficiency MELAS neuromuscular block Focal neurological signs, white matter degeneration on MRI Death 5 weeks post-surgery Nil Shenkman and colleagues (1997) 19 1 Ketamine, midazolam, propofol Leigh s syndrome Nil Naguib and colleagues (1996) 15 1 Propofol, mivacurium Mitochondrial myopathy Extreme sensitivity to mivacurium prolonged recovery Maslow and Lisbon (1993) 12 Triggering agent Nil Grattan-Smith and colleagues 16 Various agents including (1990) 10 Papaveretum (morphine and codeine) Leigh s syndrome Postop respiratory failure in three patients who received Papaveretum Burns and Shelley (1989) 2 Triggering agent Mitochondrial dysfunction Nil Ohatani and colleagues (1985) 16 1 Suxamethonium Mitochondrial dysfunction Malignant hyperthermia which included five central line insertions, one bronchoscopy, one laparotomy and one muscle biopsy. The median duration of procedure was 1 h (range ). Inhalation and i.v. agents were used to induce and maintain anaesthesia with a variety of neuromuscular blocking agents, analgesics, and other drugs (Table 3). In our series, a variety of i.v. fluids were used in 34/58 (59%) cases; in 26/34 (76%) fluid therapy began before operation. Ten per cent dextrose was used in 9/34 (26%), 0.45% saline and 5% dextrose in 6/34 (18%), Hartman s in 6/34 (18%), 0.9% saline in 4/34 (11%), 0.18% saline and 4% dextrose in 2/34 (6%), and 5% dextrose in 1/34 (3%), blood products in 1/34 (3%) case. The type of fluid was unspecified in 5/34 (15%) cases. There were no significant documented intraoperative adverse events attributable to the anaesthesia. There was one difficult intubation recorded and one desaturation related to secretions which responded to airway suctioning. There were no episodes of malignant hyperthermia or rhabdomyolysis. Three significant adverse clinical events occurred after operation (Table 4). Two were related to inadequate fluid replacement and one was a metabolic decompensation. 438
4 Mitochondrial disorders and general anaesthesia Table 2 Modified Walker diagnostic criteria for respiratory chain disorders in children. Definite diagnosis: two major OR one major plus two minor. Probable diagnosis: one major plus one minor OR at least three minor. Possible diagnosis: single major OR two minor (one of which must be clinical) Major Clinical Clinically complete RC encephalomyopathy OR mitochondrial cytopathy defined as fulfilling all three of the following conditions: unexplained combination of multisystemic symptoms to include at least three systems; progressive clinical course with episodes of exacerbation or a family history that is indicative of a mtdna mutation; and exclusion of other metabolic and non-metabolic disorders Histology.2% red ragged fibres in skeletal muscle Enzymology.2% COX-negative fibres,30% activity of any RC complex in a cell line,30% activity of the same RC complex activity in 2 tissues Functional Fibroblast ATP synthesis rates.3 SD below mean Molecular Identification of a nuclear or mtdna mutation of undisputed pathogenicity Minor Clinical Symptoms compatible with a RC defect Histology Any ragged red fibres.2% subsarcolemmal mitochondrial accumulations Widespread EM abnormalities in any tissue Enzymology 30 40% activity of ay RC complex in a cell line 30 40% activity of the same RC complex in 2 tissues Functional Fibroblast ATP synthesis rates 2 3 SD below mean Fibroblasts unable to grow on media with glucose replaced by galactose Molecular Identification of a nuclear or mtdna mutation of probable pathogenicity Metabolic One or more metabolic indicators of impaired RC function Discussion This is a large paediatric case series and represents the broad age range and clinical spectrum of multi-system involvement seen in mitochondrial disease. The variety of surgical procedures is typical of that encountered in this patient group and our series includes both elective and emergency procedures of variable duration. Anaesthetic technique was at the discretion of the anaesthetist involved and on an individual patient basis. A variety of anaesthetic agents were used and the pattern of agent use reflects that seen in standard paediatric anaesthetic practice. This review demonstrates that, despite theoretical concern about this cohort of patients, metabolic decompensation after GA is rare (one case in 58 episodes). As with any retrospective case notes review, medical records were incomplete or not available in some cases. In five cases, the GA was performed at peripheral hospital sites and these notes were not reviewed. In this series, suxamethonium was used in two cases without any adverse sequelae. In keeping with usual practice, however, non-depolarizing neuromuscular relaxants Table 3 Anaesthetic agents and other pharmacological agents in 58 procedures Induction Sevoflurane 21 Isoflurane 1 Propofol 28 Thiopentone 5 Midazolam and fentanyl 3 Maintenance Sevoflurane 21 Isoflurane 30 Sevoflurane and isoflurane 3 Propofol 4 Neuromuscular relaxants Atracurium 26 Pancuronium 1 Rocuronium 1 Suxamethonium 2 Opiates Fentanyl 24 Alfentanil 3 Morphine 2 Codeine 1 Remifentanil 1 Other Midazolam 4 Neostigmine 7 were used more frequently and no abnormal or exaggerated response was noted. Three adverse clinical events are described in this series, all of which occurred after the immediate postoperative period when the child had left the anaesthetic recovery area. The first was a 2-yr-old girl who developed hypovolaemia and required volume resuscitation after a procedure for multiple diagnostic biopsies and therapeutic aspiration of abdominal ascites. Inadequate volume replacement during surgery, in combination with the use of propofol (vasodilator effect) for induction of anaesthesia, probably contributed to the acute hypotension and hypovolaemia in this case and was unrelated to the underlying mitochondrial disease. The second case was an 8-yr-old girl who developed acute on chronic renal failure in 3 4 days after surgery for gastrostomy insertion and muscle biopsy. Gastrostomy feeding was slow to be established. Plasma lactate levels remained stable in the postoperative period and her clinical presentation was not typical of that seen in a metabolic decompensation. We therefore believe that the renal deterioration was unlikely to be related to the use of GA in mitochondrial disease. This patient has subsequently undergone another episode of GA for insertion of central line that was well tolerated and uneventful. The third case was a 1-month-old male infant who presented with seizures and neurological regression. Initial investigations demonstrated elevated plasma lactate and brain MRI changes consistent with Leigh s disease and muscle biopsy was performed at 6 weeks of age to further clarify the diagnosis. The procedure itself was 439
5 Footitt et al. Table 4 Adverse events documented in the study group Case 1 Case 2 Case 3 Procedure Diagnostic biopsies and ascitic tap Gastrostomy and muscle biopsy Muscle biopsy Duration (min) Clinical details Complex IV deficiency. Developmental delay, Complex I deficiency. Chronic renal Leigh disease seizures, nephrotic syndrome, hepatic dysfunction failure, faltering growth, lactic acidosis I.V. fluid 10% dextrose Hartman s 10% dextrose Induction agent Propofol Propofol Propofol Maintenance agent Sevoflurane Isoflurane Sevoflurane Opiate Fentanyl Fentanyl Fentanyl Benzodiazepine Midazolam Neuromuscular Atracurium Atracurium relaxant Complication Hypovolaemia Renal impairment Respiratory failure and metabolic acidosis uncomplicated and he returned to the ward after an apparently uneventful GA. Within 24 h, there was an acute deterioration with respiratory failure and metabolic acidosis with increasing plasma lactate levels. He was stabilized on the paediatric ICU, but unfortunately never recovered from this episode and died 3 days later when intensive care was withdrawn. It is difficult to clarify the impact of the surgical procedure and GA in this particular case, although there is a clear temporal relationship between the episode of GA for muscle biopsy and his metabolic decompensation. This child had severe, progressive neurometabolic disease and his clinical condition had deteriorated significantly, even in the short time since initial presentation. A previous report 10 described three patients with Leigh s disease who developed respiratory failure after GA. A variety of anaesthetic agents were used in each case, although it was noted that the same opiate-based, pre-medication (Papaveretum) was used in all three children. It is difficult, however, to draw any conclusions from this small sample. The authors highlighted pre-existing respiratory abnormalities as the only discriminating factor when comparing these three patients with others with Leigh s disease who underwent GA without a problem. In our case, no respiratory abnormality was documented before operation, although his clinical deterioration followed a similar pattern. It has been suggested that a combination of postoperative raised inflammatory mediators (inhibitors of the mitochondrial electron transport chain) in patients with an oxidative phosphorylation defect might lead to a critical degree of mitochondrial failure, particularly in the central nervous system. This may cause clinical deterioration unrelated to the nature of the anaesthetic agents used. 3 Further work in this area may help to clarify the effect of the surgical stress response in mitochondrial patients. This review of anaesthetic episodes demonstrates that routine management of mitochondrial patients undergoing GA did not differ to that seen in the normal paediatric population and our results suggest that there is no case for avoiding any particular anaesthetic agent in these patients. This is in agreement with recently published data 7 which reviewed anaesthetic morbidity after GA for muscle biopsy alone in children with mitochondrial defects. It would seem pertinent, however, to avoid the prolonged use of propofol for maintenance of anaesthesia and to use neuromuscular relaxants judiciously. Meticulous individual assessment is important due to the diverse nature of mitochondrial disease and, as with any surgical case, careful attention to fluid management is essential. Preoperative fasting in this patient group may be particularly hazardous as they have a tendency to develop lactic acidosis which will be exacerbated by periods of metabolic stress such as that seen during surgical procedures and perioperative fasting. We recommend the routine, perioperative use of lactate free i.v. fluids in all patients with mitochondrial disease undergoing GA (such as 5% dextrose 0.9% saline). I.V. fluids should be commenced during the preoperative fasting period to allow maintenance of normoglycaemia, as excessive glycolytic oxidation of glucose in this patient group may increase plasma lactate levels. As may be expected, those patients with more severe clinical disease seem to be at greater risk after GA and further work should be directed towards Leigh s disease in particular, especially those with documented variable respiratory drive. Further prospective studies will enable a thorough analysis of perioperative patient management and the use of GA in mitochondrial disease, with the aim to create evidence-based clinical guidelines. References 1 Bernier FP, Boneh A, Dennett X, et al. Diagnostic criteria for respiratory chain disorders in adults and children. Neurology 2002; 59: Burns AM, Shelley MP. Anaesthesia for patients with mitochondrial myopathy. Anaesthesia 1989; 14: Casta A, Quackenbush EJ, Houck C, et al. Perioperative white matter degeneration and death in a patient with a defect in mitochondrial oxidative phosphorylation. Anesthesiology 1997; 87:
6 Mitochondrial disorders and general anaesthesia 4 Clarke JTR. A Clinical Guide to Inherited Metabolic Diseases, 3rd Edn. Cambridge: Cambridge University Press; 14 7, Cooper MA, Fox R. Anesthesia for corrective spinal surgery in a patient with Leigh s disease. Anesth Analg 2003; 97: DiMauro S, Schon E. Mitochondrial respiratory-chain diseases. New Engl J Med 2007; 348: Driessen J, Willems S, Dercksen S, Giele J, Van der Staak F, Smeitink J. Anaesthesia-related morbidity and mortality after surgery for muscle biopsy in children with mitochondrial defects. Pediatr Anesth 2007; 17: Filosto M, Mancuso M. Mitochondrial diseases a nosological update. Acta Neurol Scand 2007; 115: Finsterer J, Sratil U, Bittner R, et al. Increased sensitivity to rocuronium and atracurium in mitochondrial myopathy. Can J Anaesth 1998; 45: Grattan-Smith PJ, Shield LK, Collins KJ. Acute respiratory failure precipitated by general anesthesia in Leigh s syndrome. J Child Neurol 1990; 5: Heinke W, Schaffranietz L. Anaesthesia for combined pancreatic and renal transplantation in a patient with mitochondrial encephalopathy a case report. Anaesthesiol Reanim 2004; 29: Maslow A, Lisbon A. Anesthetic considerations in patients with mitochondrial dysfunction. Anesth Analg 1993; 76: Morgan PG, Hoppel CL, Sedensky MM. Mitochondrial defects and anaesthetic sensitivity. Anaesthesiology 2002; 96: Munnich A. Defects of the respiratory chain. In: Fernandes J, Saudubray J-M, van den Berghe G, Walter JH, eds. Inborn Metabolic Diseases, 4th Edn. Springer, 2006; Naguib M, El Dawlatly AA, Ashour M, et al. Sensitivity to mivacurium in a patient with mitochondrial myopathy. Anesthesiology 1996; 84: Ohtani Y, Miike T, Ishitshu T, et al. A case of malignant hyperthermia with mitochondrial dysfunction. Brain Dev 1985; 7: Schapira AHV. Mitochondrial disease. Lancet 2006; 368: Sharma AD, Erb T, Schulman SR, et al. Anaesthetic considerations for a child with combined Prader Willi syndrome and mitochondrial myopathy. Paediatr Anaesth 2001; 11: Shenkman Z, Krichevski I, Elpeleg O, Joseph A, Kadari A. Can J Anaesth 1997; 44: Shipton EA, Prosser DO. Mitochondrial myopathies and anaesthesia. Eur J Anaesthesiol 2004; 21: Singh B, Low PS, Yeo JF. MELAS: a case report. Ann Acad Med 2004; 33: Thiel A, Ritzka M, Saur G. Anesthesia in mitochondrial encephalomyopathies. Anaesthesiol Intensivmed Notfallmed Schmerzther 2001; 36: Thompson VA, Wahr JA. Anaesthetic considerations in patients presenting with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome. Anesth Analg 1997; 85: Vilela H, Garcia-Fernandez J, Parodi E, et al. Anaesthetic management of a patient with MERRF syndrome. Pediatr Anesth 2005; 15: Wallace JJ, Perndt H, Skinner F, et al. Anaesthesia and mitochondrial disease. Pediatr Anaesth 1998; 8:
Mitochondrial Disease: Navigating Clinical Uncertainties, Patient Misinformation & Urban Myths
PBLD 2015 SPA Mitochondrial Disease: Navigating Clinical Uncertainties, Patient Misinformation & Urban Myths Moderators: Thomas Romanelli, M.D., Aaron Broman, MD Institution: Vanderbilt University/Monroe
More informationAnesthesia and Mitochondrial Cytopathies Bruce H. Cohen, MD, John Shoffner, MD, Glenn DeBoer, MD United Mitochondrial Disease Foundation, 1998
Introduction Anesthesia and Mitochondrial Cytopathies Bruce H. Cohen, MD, John Shoffner, MD, Glenn DeBoer, MD United Mitochondrial Disease Foundation, 1998 This article will outline some basic aspects
More informationNutritional Interventions in Primary Mitochondrial Disorders
Nutritional Interventions in Primary Mitochondrial Disorders Carolyn J Ellaway MBBS PhD FRACP CGHGSA Genetic Metabolic Disorders Service Sydney Children s Hospital Network Disciplines of Child and Adolescent
More informationEditorial Muscular dystrophy versus mitochondrial myopathy: the dilemma of the undiagnosed hypotonic child
Pediatric Anesthesia 2007 17: 1 6 doi:10.1111/j.1460-9592.2006.02106.x Editorial Muscular dystrophy versus mitochondrial myopathy: the dilemma of the undiagnosed hypotonic child ALLISON KINDER ROSS MD
More informationChapter 25. General Anesthetics
Chapter 25 1. Introduction General anesthetics: 1. Analgesia 2. Amnesia 3. Loss of consciousness 4. Inhibition of sensory and autonomic reflexes 5. Skeletal muscle relaxation An ideal anesthetic: 1. A
More informationEnteral Tube Feeding in Paediatric Mitochondrial Diseases
www.nature.com/scientificreports Received: 6 April 2017 Accepted: 23 November 2017 Published: xx xx xxxx OPEN Enteral Tube Feeding in Paediatric Mitochondrial Diseases Han Som Choi & Young-Mock Lee We
More informationPresentation and investigation of mitochondrial disease in children
Presentation and investigation of mitochondrial disease in children Andrew Morris Willink Unit, Manchester Mitochondrial function Carbohydrate Fat Respiratory chain Energy Mitochondria are the product
More informationAnaesthetic considerations and peri-operative risks in patients with liver disease
Anaesthetic considerations and peri-operative risks in patients with liver disease Dr. C. K. Pandey Professor & Head Department of Anaesthesiology & Critical Care Medicine Institute of Liver and Biliary
More informationGeneral anesthetics. Dr. Shamil AL-Noaimy Lecturer of Pharmacology Dept. of Pharmacology College of Medicine
General anesthetics Dr. Shamil AL-Noaimy Lecturer of Pharmacology Dept. of Pharmacology College of Medicine Rationale General anesthesia is essential to surgical practice, because it renders patients analgesic,
More informationAn Introduction to mitochondrial disease.
9 th September 2017 An Introduction to mitochondrial disease. Dr Andy Schaefer Consultant Neurologist and Clinical Lead NHS Highly Specialised Rare Mitochondrial Disease Service and Wellcome Trust Centre
More informationAnaesthesia recommendations for patients suffering from Mitochondrial Cytopathy, Mitochondrial Myopathy, Mitochondrial Encephalomyopathy
orphananesthesia Anaesthesia recommendations for patients suffering from Mitochondrial Cytopathy, Mitochondrial Myopathy, Mitochondrial Encephalomyopathy Disease name: Mitochondrial Cytopathy, Mitochondrial
More informationOriginal Date of issue: 01/11/2005 Last Reviewed: 01/05/2011 Version:4 Page 1 of 7
Original Date of issue: 01/11/2005 Last eviewed: 01/05/2011 Version:4 Page 1 of 7 15: Anaesthesia 15.1 General anaesthesia 15.1.1 Intravenous anaesthesia Etomidate Injection (20mg/10ml) Ketamine Injection
More informationSleep Apnea and ifficulty in Extubation. Jean Louis BOURGAIN May 15, 2016
Sleep Apnea and ifficulty in Extubation Jean Louis BOURGAIN May 15, 2016 Introduction Repetitive collapse of the upper airway > sleep fragmentation, > hypoxemia, hypercapnia, > marked variations in intrathoracic
More informationSWISS SOCIETY OF NEONATOLOGY. Prolonged arterial hypotension due to propofol used for endotracheal intubation in a newborn infant
SWISS SOCIETY OF NEONATOLOGY Prolonged arterial hypotension due to propofol used for endotracheal intubation in a newborn infant July 2001 2 Wagner B, Intensive Care Unit, University Children s Hospital
More informationMITOCHONDRIAL DISEASE. Amel Karaa, MD Mitochondrial Disease Program Massachusetts General Hospital
MITOCHONDRIAL DISEASE Amel Karaa, MD Mitochondrial Disease Program Massachusetts General Hospital Disclosures & Disclaimers United Mitochondrial Disease Foundation Research Grant North American Mitochondrial
More informationSuccinycholine: Succinylcholine has no place in pediatric anesthesia. Wads Ames MBBS FRCA
Succinycholine: Succinylcholine has no place in pediatric anesthesia Wads Ames MBBS FRCA Food And Drug Administration Created in 1906 Responsible for protecting and promoting public health through the
More informationNüchternzeiten in der Kinderanästhesie nüchtern betrachtet
Nüchternzeiten in der Kinderanästhesie nüchtern betrachtet Pädiatrische Traunseeklausur 2018 04. - 05. Mai 2018 Gmunden (A) Prof. Dr. med. Markus Chefarzt Anästhesieabteilung, Universitäts-Kinderspital
More informationNEUROMUSCULAR BLOCKING AGENTS
NEUROMUSCULAR BLOCKING AGENTS Edward JN Ishac, Ph.D. Associate Professor, Pharmacology and Toxicology Smith 742, 828-2127, Email: eishac@vcu.edu Learning Objectives: 1. Understand the physiology of the
More informationINTUBATING CONDITIONS AND INJECTION PAIN
INTUBATING CONDITIONS AND INJECTION PAIN - Cisatracurium or Rocuronium versus Rocuronium-Cisatracurium Combination - AHED ZEIDAN *, NAZIH NAHLE *, HILAL MAALIKI ** AND ANIS BARAKA *** Summary The present
More informationTraining Syllabus CLINICAL SYLLABUS
Training Syllabus CLINICAL SYLLABUS SYLLABUS FOR TRAINING IN CLINICAL PAEDIATRIC METABOLIC MEDICINE Updated July 2006 This syllabus is intended as a guide. Whilst the training should be comprehensive,
More informationSEDATION FOR SMALL PROCEDURES
SEDATION FOR SMALL PROCEDURES Sinno Simons Erasmus MC Sophia Children s Hospital Rotterdam, the Netherlands s.simons@erasmusmc.nl SEDATION in newborns How and when How to evaluate How to dose Why to use
More informationFatty Acid Oxidation Disorders- an update. Fiona Carragher Biochemical Sciences, GSTS Pathology St Thomas Hospital, London
Fatty Acid Oxidation Disorders- an update Fiona Carragher Biochemical Sciences, GSTS Pathology St Thomas Hospital, London An update. Overview of metabolism Clinical presentation and outcome Diagnostic
More informationvariant led to a premature stop codon p.k316* which resulted in nonsense-mediated mrna decay. Although the exact function of the C19L1 is still
157 Neurological disorders primarily affect and impair the functioning of the brain and/or neurological system. Structural, electrical or metabolic abnormalities in the brain or neurological system can
More informationDOCUMENT CONTROL PAGE
DOCUMENT CONTROL PAGE Title Title: UNDERGOING SPINAL DEFORMITY SURGERY Version: 2 Reference Number: Supersedes Supersedes: all other versions Description of Amendment(s): Revision of analgesia requirements
More informationCancer in the United States
https://www.cancer.gov/aboutcancer/understanding/statistics https://www.cancer.gov/aboutcancer/understanding/statistics 09/05/2018 Anesthesia for Cancer Surgery: How we can impact survival Paul G. Tarasi
More informationThe Organism as a system
The Organism as a system PATIENT 1: Seven-year old female with a history of normal development until age two. At this point she developed episodic vomiting, acidosis, epilepsy, general weakness, ataxia
More informationFundamental Knowledge: List of topics relevant to PIC that will have been covered in membership examinations. They will not be repeated here.
Disclaimer: The Great Ormond Street Paediatric Intensive Care Training Programme was developed in 2004 by the clinicians of that Institution, primarily for use within Great Ormond Street Hospital and the
More informationCHAPTER 11. General and Local Anesthetics. Anesthetics. Anesthesia. Eliza Rivera-Mitu, RN, MSN NDEG 26 A
CHAPTER 11 General and Local Anesthetics Eliza Rivera-Mitu, RN, MSN NDEG 26 A Anesthetics Agents that depress the central nervous system (CNS) Depression of consciousness Loss of responsiveness to sensory
More informationAwake regional versus general anesthesia in preterms and ex-preterm infants for herniotomy
Awake regional versus general anesthesia in preterms and ex-preterm infants for herniotomy Department of Anaesthesia University Children s Hospital Zurich Switzerland Epidemiology Herniotomy needed in
More informationAnaesthesia recommendations for patients suffering from. Glutaric acidemia type 1
orphananesthesia Anaesthesia recommendations for patients suffering from Disease name: Glutaric acidemia type 1 Glutaric acidemia type 1 ICD 10: E72.3 - Disorders of lysine and hydroxylysine metabolism
More informationDr. Gavin Parker PINCHER CREEK AB 140
Society of Rural Physicians of Canada 26TH ANNUAL RURAL AND REMOTE MEDICINE COURSE ST. JOHN'S NEWFOUNDLAND AND LABRADOR APRIL 12-14, 2018 Dr. Gavin Parker PINCHER CREEK AB 140 MALIGNANT HYPERTHERMIA Malignant
More informationCricoid pressure: useful or dangerous?
Cricoid pressure: useful or dangerous? Francis VEYCKEMANS Cliniques Universitaires Saint Luc Bruxelles (2009) Controversial issue - Can J Anaesth 1997 JR Brimacombe - Pediatr Anesth 2002 JG Brock-Utne
More informationSetting The setting was a hospital (tertiary care). The economic study was carried out in Ankara, Turkey.
Inhalation versus total intravenous anesthesia for lumbar disc herniation: comparison of hemodynamic effects, recovery characteristics, and cost Ozkose Z, Ercan B, Unal Y, Yardim S, Kaymaz M, Dogulu F,
More informationGeneral Anesthesia. Mohamed A. Yaseen
General Anesthesia Mohamed A. Yaseen M.S,c Surgery Before Anesthesia General Anesthesia ( GA ) Drug induced absence of perception of all sensation allowing surgery or other painful procedure to be carried
More informationMitochondrial Disease & its Anesthetic Considerations. Stephen Okoth BSN, SRNA (Sr.) York College of PA/Wellspan Health NAP
Mitochondrial Disease & its Anesthetic Considerations tephen Okoth BN, RNA (r.) York College of PA/Wellspan Health NAP Objectives Discuss the structure of the Mitochondrion Discuss the main function of
More informationMetabolic Precautions & ER Recommendations
Metabolic Precautions & ER Recommendations * To whom correspondence Sumit Parikh, should MD be addressed Center for Pediatric Neurology Cleveland Clinic Cleveland, OH UMDF 2010 The catabolic state Entering
More informationTHIAMINE TRANSPORTER TYPE 2 DEFICIENCY
THIAMINE TRANSPORTER TYPE 2 DEFICIENCY WHAT IS THE THIAMINE TRANSPORTER TYPE 2 DEFICIENCY (hthtr2)? The thiamine transporter type 2 deficiency (hthtr2) is a inborn error of thiamine metabolism caused by
More informationChildhood Obesity: Anesthetic Implications
Childhood Obesity: Anesthetic Implications The Changing Practice of Anesthesia 2015 UCSF Department of Anesthesia and Perioperative Care Marla Ferschl, MD Associate Professor of Anesthesia University of
More informationChapter 18. Skeletal Muscle Relaxants (Neuromuscular Blocking Agents)
Chapter 18 Skeletal Muscle Relaxants (Neuromuscular Blocking Agents) Uses of Neuromuscular Blocking Facilitate intubation Surgery Agents Enhance ventilator synchrony Reduce intracranial pressure (ICP)
More informationSign up to receive ATOTW weekly -
ANAPHYLAXIS ANAESTHESIA TUTORIAL OF THE WEEK 38 1 th DECEMBER 2006 Dr. Sara Rees Cardiff, UK Case History You are anaesthetising a fit and well 40 year old woman for total abdominal hysterectomy for menorrhagia.
More information7 Medical Genetics. Hemoglobinopathies. Hemoglobinopathies. Protein and Gene Structure. and Biochemical Genetics
SESSION 7 Medical Genetics Hemoglobinopathies and Biochemical Genetics J a v a d F a s a J a m s h i d i U n i v e r s i t y o f M e d i c a l S c i e n c e s, N o v e m b e r 2 0 1 7 Hemoglobinopathies
More informationChildhood mitochondrial encephalomyopathies: clinical course, diagnosis, neuroimaging findings, mtdna mutations and outcome in six children
Lu and Huang Italian Journal of Pediatrics 2013, 39:60 ITALIAN JOURNAL OF PEDIATRICS CASE REPORT Open Access Childhood mitochondrial encephalomyopathies: clinical course, diagnosis, neuroimaging findings,
More informationASSESSMENT OF THE PAEDIATRIC NEEDS ANAESTHESIOLOGY DISCLAIMER
European Medicines Agency Evaluation of Medicines for Human Use ASSESSMENT OF THE PAEDIATRIC NEEDS ANAESTHESIOLOGY London, October 2006 Doc. Ref: EMEA/405166/2006 DISCLAIMER The Paediatric Working Party
More informationCURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi
2 CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE Dr. Bahar Naghavi Assistant professor of Basic Science Department, Shahid Beheshti University of Medical Sciences, Tehran,Iran 3 Introduction Over 4000
More informationMetabolic diseases of the liver
Metabolic diseases of the liver Central role in metabolism Causes and mechanisms of dysfunction Clinical patterns of metabolic disease Clinical approach to problem-solving Specific disorders Liver s central
More informationJMSCR Vol 04 Issue 01 Page January 2016
www.jmscr.igmpublication.org Impact Factor 3.79 Index Copernicus Value: 5.88 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: http://dx.doi.org/10.18535/jmscr/v4i1.04 Haemodynamic Effects during Induction in
More informationWhat is MH? Malignant Hyperthermia (MH)! Malignant Hyperthermia (MH) Malignant Hyperthermia (MH) ! The underlying physical mechanismintracellular
10/2/13 What is MH? Libby Morse BSN RN CPAN An inherited disorder of skeletal muscle triggered in susceptible humans in most instances by inhalation agents and/ or succinylcholine, resulting in hypermetabolism,
More informationEffect of Vecuronium in different age group
Original Research Article Effect of Vecuronium in different age group Bharti Rajani 1, Hitesh Brahmbhatt 2, Hemlata Chaudhry 2, Hiren Parmar 3* 1 Associate Professor, Department of Anesthesiology, GMERS
More informationAnesthesia and Neuromuscular Blockade: A Guide for Hospital Pharmacists. Upon completion of this activity, participants will be better able to:
Anesthesia and Neuromuscular Blockade: A Guide for Hospital Pharmacists EDUCATIONAL OBJECTIVES Upon completion of this activity, participants will be better able to: 1. Understand the use of neuromuscular
More informationSuspected Isoflurane Induced Hepatitis from Cross Sensitivity in a Post Transplant for Fulminant Hepatitis from Halothane.
ISPUB.COM The Internet Journal of Anesthesiology Volume 25 Number 1 Suspected Isoflurane Induced Hepatitis from Cross Sensitivity in a Post Transplant for Fulminant Hepatitis from Halothane. V Sampathi,
More informationPrinted copies of this document may not be up to date, obtain the most recent version from
Children s Acute Transport Service Clinical Guidelines Acute Severe Asthma Document Control Information Author E Randle Author Position CATS Consultant Document Owner E Polke Document Owner Position Co-ordinator
More information8/26/14. Disclosures. Objectives. None
Disclosures None Objectives Understand Importance of Pediatric Obesity Impact on Physiology Preoperative Assessment Intra-operative Management PACU & the obese pediatric Patient 1 Gender specific charts
More informationComparative study of intubating conditions after Rocuronium and Suxamethonium (study of 80 cases)
ISPUB.COM The Internet Journal of Anesthesiology Volume 20 Number 1 Comparative study of intubating conditions after Rocuronium and Suxamethonium (study of 80 cases) K Bhati, V Parmar Citation K Bhati,
More informationAnaesthesia recommendations for patients suffering from Central Core Disease
orphananesthesia Anaesthesia recommendations for patients suffering from Central Core Disease Disease name: Central Core disease ICD 10: G71.2 Synonyms: Shy-McGee syndrome Central core disease (CCD) is
More informationNEOSTIGMINE VERSUS SUGAMMADEX FOR REVERSAL OF NEUROMUSCULAR BLOCK
EDITORIAL NEOSTIGMINE VERSUS SUGAMMADEX FOR REVERSAL OF NEUROMUSCULAR BLOCK Neostigmine is the classic acetylcholinesterase antagonist, which is widely used for reversal of neuromuscular block of all nondepolarising
More informationPOSTGRADUATE INSTITUTE OF MEDICINE UNIVERSITY OF COLOMBO. MD (ANAESTHESIOLOGY) FINAL EXAMINATION AUGUST 2011 Time : 1.00 p.m p.m.
POSTGRADUATE INSTITUTE OF MEDICINE UNIVERSITY OF COLOMBO MD (ANAESTHESIOLOGY) FINAL EXAMINATION AUGUST 2011 Date : 5 th August 2011 Time : 1.00 p.m. 4.00 p.m. Answer any three questions. Answer each question
More informationAnesthesia recommendations for patients suffering from. Malignant Hyperthermia
orphananesthesia Anesthesia recommendations for patients suffering from Disease name: Malignant Hyperthermia ICD 10: T88.3 Synonyms: Malignant Hyperpyrexia Malignant Hyperthermia Malignant hyperthermia
More informationRole and safety of epidural analgesia
Anaesthesia for Liver Resection Surgery The Association of Anaesthetists Seminars 21 Portland Place, London Thursday 15 th December 2005 Role and safety of epidural analgesia Lennart Christiansson MD,
More informationMastocytosis and Anaesthesia Advice for patients
What is mastocytosis? Mastocytosis is a very rare disorder affecting mast cells. In people who do not have mastocytosis, mast cells are triggered during allergy attacks. They release substances that cause
More informationAnesthetic Techniques in Endoscopic Sinus and Skull Base Surgery
Anesthetic Techniques in Endoscopic Sinus and Skull Base Surgery Martha Cordoba Amorocho, MD Iuliu Fat, MD Supplement to Cordoba Amorocho M, Fat I. Anesthetic techniques in endoscopic sinus and skull base
More informationEvaluation of Postoperative Complications Occurring in Patients after Desflurane or Sevoflurane in Outpatient Anaesthesia: A Comparative Study
Original article Evaluation of Postoperative Complications Occurring in Patients after Desflurane or Sevoflurane in Outpatient Anaesthesia: A Comparative Study Shishir Ramachandra Sonkusale 1, RajulSubhash
More informationPharmacology of the Neuromuscular Junction (NMJ)
Pharmacology of the Neuromuscular Junction (NMJ) Edward JN Ishac, Ph.D. Professor Smith Building, Room 742 eishac@vcu.edu 828 2127 Department of Pharmacology and Toxicology Medical College of Virginia
More informationFinal FRCA Written PAEDIATRICS Past Paper Questions November March 2014
Final FRCA Written PAEDIATRICS Past Paper Questions November 1996- March 2014 March 2014 A 5-year-old patient presents for a myringotomy and grommet insertion as a day case. During your pre-operative assessment
More informationA HOT DAY IN THE OFFICE DR. M HAINES. FANZCA
A HOT DAY IN THE OFFICE DR. M HAINES. FANZCA DIFFERENTIAL DIAGNOSIS Inadequate anaesthesia Sepsis Thyrotoxicosis Phaechromocytoma Neuroleptic malignant syndrome Anti-dopaminergics Drug overdose Eg.Amphetamines
More informationCLINICAL GUIDELINES ID TAG
CLINICAL GUIDELINES ID TAG Title: Author: Speciality / Division: Directorate: Guideline for the perioperative fluid management in children Kieran O Connor Anaesthetics ATICS Date Uploaded: 26/04/2016 Review
More informationECT Workshop. Rahul Bajekal Consultant Anaesthetist Newcastle upon Tyne 23 November 2017
ECT Workshop Rahul Bajekal Consultant Anaesthetist Newcastle upon Tyne 23 November 2017 My role To attenuate seizure appropriately Manage comorbidity Best place to treat? What we don t like Complex comorbidity
More informationTransfusion & Mortality. Philippe Van der Linden MD, PhD
Transfusion & Mortality Philippe Van der Linden MD, PhD Conflict of Interest Disclosure In the past 5 years, I have received honoraria or travel support for consulting or lecturing from the following companies:
More informationRobert Barski. Biochemical Genetics St James s University Hospital, Leeds. MetBioNet IEM Introductory Training
Robert Barski Biochemical Genetics St James s University Hospital, Leeds Lactate is produced as the fate of anaerobic metabolism of pyruvate. It is an important intermediary metabolite especially with
More informationPharmacology of the Neuromuscular Junction (NMJ)
Pharmacology of the Neuromuscular Junction (NMJ) Edward JN Ishac, Ph.D. Professor Smith Building, Room 742 eishac@vcu.edu 828 2127 Department of Pharmacology and Toxicology Medical College of Virginia
More informationPrinted copies of this document may not be up to date, obtain the most recent version from
Children s Acute Transport Service Clinical Guidelines Septic Shock Document Control Information Author Claire Fraser P.Ramnarayan Author Position tanp CATS Consultant Document Owner E. Polke Document
More informationHypotension after induction, corrected with 20 mg ephedrine x cc LR EBL 250cc Urine output:
Terry C. Wicks, CRNA, MHS Catawba Valley Medical Center Hickory, North Carolina 63 y.o., 5 2, 88 kg female for hand assisted laparoscopic tranversecolectomy Co-morbidities include: Hypertension controlled
More informationAnaesthesia for ECT. Session 1. Dr Richard Cree Consultant in Anaesthesia & ICU. Roseberry Park Hospital and The James Cook Hospital, Middlesbrough
Anaesthesia for ECT Session 1 Dr Richard Cree Consultant in Anaesthesia & ICU Roseberry Park Hospital and The James Cook Hospital, Middlesbrough Anaesthesia for ECT CHAPTERS 1. The principles of anaesthesia
More informationEvaluation of intubation condition following administration of rocuronium in comparison to atracurium in paediatric patients
Original Article Evaluation of intubation condition following administration of rocuronium in comparison to atracurium in paediatric Abdul Kuddus Khan 1*, MM Abdul Wadud 2, Azizul Gafur 3, Rafayetullah
More informationPAAQS Reference Guide
Q. 1 Patient's Date of Birth (DOB) *Required Enter patient's date of birth PAAQS Reference Guide Q. 2 Starting Anesthesiologist *Required Record the anesthesiologist that started the case Q. 3 Reporting
More informationNewcastle Mitochondrial Disease Guidelines
Newcastle Mitochondrial Disease Guidelines Epilepsy in Adult Mitochondrial Disease: Investigation and Management First published August 2010 Updated January 2013 1 Contents Introduction 3 Patient Centered
More informationPostoperative cognitive dysfunction a neverending story
Postoperative cognitive dysfunction a neverending story Adela Hilda Onuţu, MD, PhD Cluj-Napoca, Romania adela_hilda@yahoo.com No conflict of interest Contents Postoperative cognitive dysfunction (POCD)
More informationThe University of Arizona Pediatric Residency Program. Primary Goals for Rotation. Genetics
The University of Arizona Pediatric Residency Program Primary Goals for Rotation Genetics 1. GOAL: Understand the role of the pediatrician in preventing genetic disease, and in counseling and screening
More informationRole of IONM in reducing the incidence and severity in pediatric patients with AIS
Role of IONM in reducing the incidence and severity in pediatric patients with AIS Mohamed Nassef M.D PGY 2 ANESTHESIA McMaster University DEC 9, 2015 Objectives: Literature Review on neurological complications
More informationThe effect of desflurane on rocuronium onset, clinical duration and maintenance requirements
(Acta Anaesth. Belg., 2006, 57, 349-353) The effect of desflurane on rocuronium onset, clinical duration and maintenance requirements R. G. STOUT (*), T. J. GAN (**), P. S. A. GLASS (***), D. G. SILVERMAN
More informationWild Child in the PACU: Update on Emergence Agitation
Wild Child in the PACU: Update on Emergence Agitation Constance S. Houck, MD Senior Associate in Perioperative Anesthesia Children s Hospital, Boston Assistant Professor of Anaesthesia Harvard Medical
More informationOBJECTIVES OF TRAINING FOR THE ANAESTHESIA TERM
College of Intensive Care Medicine of Australia and New Zealand ABN: 16 134 292 103 Document type: Training Date established: 2007 Date last reviewed: 2014 OBJECTIVES OF TRAINING FOR THE ANAESTHESIA TERM
More informationGeneral anesthesia. No single drug capable of achieving these effects both safely and effectively.
General anesthesia General anesthesia is essential to surgical practice, because it renders patients analgesic, amnesia, and unconscious reflexes, while causing muscle relaxation and suppression of undesirable
More informationGaucher disease 3/22/2009. Mendelian pedigree patterns. Autosomal-dominant inheritance
Mendelian pedigree patterns Autosomal-dominant inheritance Autosomal dominant Autosomal recessive X-linked dominant X-linked recessive Y-linked Examples of AD inheritance Autosomal-recessive inheritance
More informationSYLLABUS FOR TRAINING IN CLINICAL PAEDIATRIC METABOLIC MEDICINE
SYLLABUS FOR TRAINING IN CLINICAL PAEDIATRIC METABOLIC MEDICINE Updated December 2014: Vassili Valayannopoulos and Andrew Morris Paediatrics is an independent medical specialty based on the knowledge and
More informationKurt Baker-Watson, MD Associate Professor
Kurt Baker-Watson, MD Associate Professor Anesthetics Previous types, complications, satisfaction, familial history of complications, acute and chronic pain issues Airway Dentition/dental appliances, temporomandibular
More informationBiochemistry of cellular organelles
Kontinkangas, L101A Biochemistry of cellular organelles Lectures: 1. Membrane channels; 2. Membrane transporters; 3. Soluble lipid/metabolite-transfer proteins; 4. Mitochondria as cellular organelles;
More informationCLINICAL SIGNS SUGGESTIVE OF A NEUROMETABOLIC DISEASE. Bwee Tien Poll-The Amsterdam UMC The Netherlands
CLINICAL SIGNS SUGGESTIVE OF A NEUROMETABOLIC DISEASE Bwee Tien Poll-The Amsterdam UMC The Netherlands FRAMEWORK OF PRINCIPALS 1. Problem-oriented clinical approach 2. Biomarkers in plasma, urine, CSF
More informationDisclosure. Objectives 9/13/2018. NIA/NIH 1R03AG (PI-Bentov) More than Start low go slow. start low go slow
Sedation and analgesia in geriatric trauma Sept 2018 Itay Bentov MD PhD Disclosure NIA/NIH 1R03AG042353 (PI-Bentov) More than Start low go slow start low go slow Objectives List age-related physiologic
More informationMalignant Hyperthermia: What the ICU Needs to Know
Malignant Hyperthermia: What the ICU Needs to Know Objectives 1. Compare the pathophysiology of malignant hyperthermia (MH) with presenting signs/symptoms in a critical care environment. 2. Identify critical,
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Acetaminophen, for geriatric surgical patients, 569 570 Acute kidney injury, critical care issues in geriatric patients with, 555 556
More informationNeurogenic Muscle Weakness, Ataxia, and Retinitis Pigmentosa (NARP) Genetic Testing Policy
Neurogenic Muscle Weakness, Ataxia, and Retinitis Pigmentosa (NARP) Genetic Testing Policy Procedure(s) addressed by this policy: Procedure Code(s) MT-ATP6 Targeted Mutation Analysis 81401 Whole Mitochondrial
More informationFamily Feud SPA Myron Yaster, MD
Family Feud SPA 2014 Myron Yaster, MD Richard J Traystman Professor, Departments of Anesthesiology, Critical Care Medicine, Pediatrics, and Neurosurgery The Johns Hopkins Medical Institutions Aubrey Maze,
More informationPeri-Operative Management: Guidelines for Inpatient Management of Children with Sickle Cell Disease
Version 02 Approved by Interprofessional Patient Care Committee: September 16, 2016 1.0 Background Children with Sickle Cell are at risk of developing post-operative Acute Chest Syndrome. With improvements
More informationTracheal intubation in children after induction of anesthesia with propofol and remifentanil without a muscle relaxant
Original Article Tracheal intubation in children after induction of anesthesia with propofol and remifentanil without a muscle relaxant Mirmohammad Taghi Mortazavi, 1 Masood Parish, 1 Naghi Abedini, 2
More informationAirway management problem during anaesthesia. Airway management problem in ICU / HDU. Airway management problem occurring in the Emergency Department
4th National Audit Project of the Royal College of Anaesthetists: Major Complications of Airway Management in the UK Please select one form from the list below Airway management problem during anaesthesia
More informationANESTHESIA EXAM (four week rotation)
SPARROW HEALTH SYSTEM ANESTHESIA SERVICES ANESTHESIA EXAM (four week rotation) Circle the best answer 1. During spontaneous breathing, volatile anesthetics A. Increase tidal volume and decrease respiratory
More informationUpdate on Anesthetic Toxicity in Children
Update on Anesthetic Toxicity in Children Piyush Patel, MD, FRCPC Professor of Anesthesiology University of California, San Diego VA Medical Center, San Diego ppatel@ucsd.edu Disclosures No commercial
More informationEffect Of Inhaled Anesthetics Gases On Health Staff Health Status In Al-Najaf City
Effect Of Inhaled Anesthetics Gases On Health Staff Health Status In Al-Najaf City Ibrahim A. Kadhim Al-Ashour, Diaa K. Abd-Ali, Mansour A. Fallah, Iman Q. Kteo Abstract: Exposure of workers to waste anaesthetic
More informationAbnormalities of Intermediary Metabolism in Barth Syndrome
Abnormalities of Intermediary Metabolism in Barth Syndrome Richard I. Kelley, M.D., Ph.D. Kennedy Krieger Institute Department of Pediatrics Johns Hopkins University Is Barth Syndrome a Mitochondrial Disease?
More informationLieven Lagae Department of Paediatric Neurology Leuven University Leuven, Belgium. Management of acute seizure settings from infancy to adolescence
Lieven Lagae Department of Paediatric Neurology Leuven University Leuven, Belgium Management of acute seizure settings from infancy to adolescence Consequences of prolonged seizures Acute morbidity and
More information